Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP741045.RAcBbs24mThbaKKv1eCHH3jGsL78oXPuiCIj1FwQEaNfk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP741045.RAcBbs24mThbaKKv1eCHH3jGsL78oXPuiCIj1FwQEaNfk130_assertion type Assertion NP741045.RAcBbs24mThbaKKv1eCHH3jGsL78oXPuiCIj1FwQEaNfk130_head.
- NP741045.RAcBbs24mThbaKKv1eCHH3jGsL78oXPuiCIj1FwQEaNfk130_assertion description "[In this study, we show that the adenoma prevention activity of the COX-2 inhibitor celecoxib requires the concomitant presence of the 15-hydroxyprostaglandin dehydrogenase (15-PGDH) tumor suppressor gene, and that loss of 15-PGDH expression imparts resistance to celecoxib's anti-tumor effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP741045.RAcBbs24mThbaKKv1eCHH3jGsL78oXPuiCIj1FwQEaNfk130_provenance.
- NP741045.RAcBbs24mThbaKKv1eCHH3jGsL78oXPuiCIj1FwQEaNfk130_assertion evidence source_evidence_literature NP741045.RAcBbs24mThbaKKv1eCHH3jGsL78oXPuiCIj1FwQEaNfk130_provenance.
- NP741045.RAcBbs24mThbaKKv1eCHH3jGsL78oXPuiCIj1FwQEaNfk130_assertion SIO_000772 19470469 NP741045.RAcBbs24mThbaKKv1eCHH3jGsL78oXPuiCIj1FwQEaNfk130_provenance.
- NP741045.RAcBbs24mThbaKKv1eCHH3jGsL78oXPuiCIj1FwQEaNfk130_assertion wasDerivedFrom befree-2016 NP741045.RAcBbs24mThbaKKv1eCHH3jGsL78oXPuiCIj1FwQEaNfk130_provenance.
- NP741045.RAcBbs24mThbaKKv1eCHH3jGsL78oXPuiCIj1FwQEaNfk130_assertion wasGeneratedBy ECO_0000203 NP741045.RAcBbs24mThbaKKv1eCHH3jGsL78oXPuiCIj1FwQEaNfk130_provenance.